You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Total Androgen Suppression

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Boston (Flutamide (Eulexin) and Lupron or Zoladex, External Beam Radiotherapy)

Completed
  • Prostate Cancer
  • Flutamide (Eulexin) and Lupron or Zoladex
  • External Beam Radiotherapy
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Dec 16, 2021

Adenocarcinoma of the Prostate Trial in Montreal (Androgen suppression plus radiation therapy)

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • Androgen suppression plus radiation therapy
  • Montreal, Quebec, Canada
  • +1 more
Jan 30, 2023

Prostate Cancer Trial in United States (Radiation, Androgen Suppression Therapy)

Recruiting
  • Prostate Cancer
  • Radiation
  • Androgen Suppression Therapy
  • Scottsdale, Arizona
  • +3 more
Oct 24, 2021

Prostate Cancer Trial in United States (Niraparib, Leuprolide, Abiraterone Acetate)

Recruiting
  • Prostate Cancer
  • Ann Arbor, Michigan
  • +3 more
Oct 18, 2022

Prostate Cancer Trial in Boston (Docetaxel, Androgen Hormonal Suppression and Radiation, Androgen Suppression Therapy and

Completed
Has Results
  • Prostate Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute and (Sanofi-Aventis Consortium)
Jan 6, 2022

Prostate Cancer Trial in Baltimore (Flutamide, Placebo)

Recruiting
  • Prostate Cancer
  • Baltimore, Maryland
    SKCCC at Johns Hopkins
Sep 2, 2021

Aminophylline Bolus on TCI Concentrations at Burst Suppression

Recruiting
  • Anesthesia Brain Monitoring
  • Treviso, TV, Italy
    Treviso Regional Hospital
Nov 18, 2023

Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Scottsdale, Rochester

Active, not recruiting
  • Prostate Adenocarcinoma
  • +5 more
  • Androgen Suppression
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Jan 5, 2023

Prostate Cancer Trial in London (Radiation, Androgen Suppression)

Completed
  • Prostate Cancer
  • Radiation
  • Androgen Suppression
  • London, Ontario, Canada
    London Regional Cancer Program of the Lawson Health Research Ins
Jun 1, 2021

Cancer of the Prostate Trial in United States (BHR-200 (0.36% transdermal 17ß-estradiol gel), Placebo)

Terminated
Has Results
  • Cancer of the Prostate
  • BHR-200 (0.36% transdermal 17β-estradiol gel)
  • Placebo
  • Tucson, Arizona
  • +11 more
Mar 8, 2022

Adenocarcinoma of the Prostate, Stage III Prostate Cancer Trial in Los Angeles (radiation, other, drug)

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • Stage III Prostate Cancer
  • stereotactic body radiation therapy
  • +3 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Apr 28, 2022

Hyperandrogenism, Polycystic Ovary Syndrome, Puberty Trial in Charlottesville (Micronized progesterone, Spironolactone, Placebo)

Recruiting
  • Hyperandrogenism
  • +2 more
  • Micronized progesterone
  • +2 more
  • Charlottesville, Virginia
    University of Virginia Clinical Research Unit
May 16, 2022

Prostate Cancer Trial in Sherbrooke (Radiotherapy 70 Gy, Radiotherapy 76 Gy, Androgen blockade)

Active, not recruiting
  • Prostate Cancer
  • Radiotherapy 70 Gy
  • +2 more
  • Sherbrooke, Quebec, Canada
    Centre de Recherche Clinique du CHUS
May 20, 2022

Prostate Cancer Trial in Surrey, Victoria (stereotactic ablative radiotherapy, external beam radiation therapy, Zoladex ®)

Active, not recruiting
  • Prostate Cancer
  • stereotactic ablative radiotherapy
  • +2 more
  • Surrey, British Columbia, Canada
  • +1 more
Oct 26, 2020

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in New Brunswick, Portland

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • ipilimumab
  • laboratory biomarker analysis
  • New Brunswick, New Jersey
  • +1 more
Sep 23, 2020

Polycystic Ovary Syndrome Trial (Ganirelix)

Not yet recruiting
  • Polycystic Ovary Syndrome
  • (no location specified)
Feb 20, 2023

Androgen Deprivation Therapy, Prostate Cancer, Hypertension Trial (Gonadotropin-Releasing Hormone Agonist, Androgen receptor

Not yet recruiting
  • Androgen Deprivation Therapy
  • +4 more
  • Gonadotropin-Releasing Hormone Agonist
  • +2 more
  • (no location specified)
Jan 18, 2023

Prostate Cancer Trial in Canada (bicalutamide, buserelin, cyproterone acetate)

Completed
  • Prostate Cancer
  • Calgary, Alberta, Canada
  • +28 more
Jun 21, 2021

Oligometastatic Hormone Sensitive Prostate Cancer Trial in Florence (SBRT on all sites of metastatic disease+Apalutamide)

Not yet recruiting
  • Oligometastatic Hormone Sensitive Prostate Cancer
  • SBRT on all sites of metastatic disease+Apalutamide
  • Florence, Italy
    AOU Careggi Radiation Oncology Unit
Jan 29, 2023

Adenocarcinoma of the Prostate Trial in Jacksonville (HR-A, HR-B)

Recruiting
  • Adenocarcinoma of the Prostate
  • HR-A
  • HR-B
  • Jacksonville, Florida
    University of Florida Health Proton Therapy Institute
Mar 14, 2022

Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)

Recruiting
  • Triple Negative Breast Cancer
  • +5 more
  • Manchester, Greater Manchester, United Kingdom
  • +6 more
Jan 5, 2023

Prostate Cancer Trial in Worldwide (Relugolix, Leuprolide Acetate)

Completed
Has Results
  • Prostate Cancer
  • Tucson, Arizona
  • +161 more
Jan 6, 2022

HIV Trial (Tetanus Toxoid Vaccine, Hydroxyurea, Didanosine)

Withdrawn
  • HIV Infections
  • Tetanus Toxoid Vaccine
  • +2 more
  • (no location specified)
Oct 28, 2021

Prostate Cancer Trial in Jacksonville (< 15% risk of + LN, > 15% risk of + LN)

Active, not recruiting
Has Results
  • Prostate Cancer
  • < 15% risk of + LN
  • > 15% risk of + LN
  • Jacksonville, Florida
    University of Florida Proton Therapy Institute
Dec 1, 2021

Immune Suppression Trial in Mansourah (Total intravenous anesthesia group, Total intravenous plus block group)

Completed
  • Immune Suppression
  • Total intravenous anesthesia group
  • Total intravenous plus block group
  • Mansourah, Dakahlia, Egypt
    Mansoura University Hospital
Sep 16, 2020